Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

Valeant Pharmaceuticals International, Inc. (VRX)

-NYQ

74.82 Down 0.71(0.94%) 4:04PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Net Income (116,025) 159,559   (208,193)
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,022,624  639,706  275,976  
Adjustments To Net Income3,257  (21,673)217,272  
Changes In Accounts Receivables(219,431)(164,581)25,187  
Changes In Liabilities(8,370)42,067  (61,908)
Changes In Inventories(80,304)(11,521)7,463  
Changes In Other Operating Activities54,827  (3,084)7,394  
Total Cash Flow From Operating Activities 656,578   640,473   263,191  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(107,638)(58,515)(16,823)
Investments617,574  5,552  7,965  
Other Cash flows from Investing Activities(3,475,657)(2,755,545)237,797  
Total Cash Flows From Investing Activities (2,965,721) (2,808,508) 228,939  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -  (356,291)
Sale Purchase of Stock(257,698)(650,003)(1,705)
Net Borrowings3,470,677  2,770,687  200,584  
Other Cash Flows from Financing Activities(134,999)(158,381)(51,306)
Total Cash Flows From Financing Activities 3,057,368   1,948,165   (213,283)
Effect Of Exchange Rate Changes3,755  (10,288)959  
Change In Cash and Cash Equivalents 751,980   (230,158) 279,806  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.